The DNA damage response (DDR) protein 53BP1 protects DNA ends from excessive resection in G1, and thereby favors repair by nonhomologous endjoining (NHEJ) as opposed to homologous recombination (HR). During S phase, BRCA1 antagonizes 53BP1 to promote HR. The pro-NHEJ and antirecombinase functions of 53BP1 are mediated in part by RIF1, the only known factor that requires 53BP1 phosphorylation for its recruitment to double-strand breaks (DSBs). Here, we show that a 53BP1 phosphomutant, 53BP1
INTRODUCTION
Class switch recombination (CSR) is initiated by activationinduced cytidine deaminase (AID), which generates multiple double-strand breaks (DSBs) at highly repetitive immunoglobulin (Ig) switch regions. Paired distal DSBs are then rejoined by nonhomologous end-joining (NHEJ), thereby replacing Igm by a downstream constant region (Igg, Igε, or Iga) . Alternatively, if DSBs persist, a homology-driven pathway that involves resection of repetitive switch regions, can repair DSBs locally. Such abortive ''intraswitch'' recombination events are increased at the expense of CSR in the absence of 53BP1 (Reina-San-Martin et al., 2007) , a key suppressor of end resection Bouwman et al., 2010; Bunting et al., 2010; Cao et al., 2009; Difilippantonio et al., 2008) .
In addition to its productive effect on CSR, 53BP1 blocks DNA ends from resection in BRCA1-deficient cells, leading to toxic radial chromosomes that arise from NHEJ (Bouwman et al., 2010; Bunting et al., 2010 Bunting et al., , 2012 Cao et al., 2009) . Deletion of 53BP1 leads to deposition of homologous recombination (HR) factors RPA and RAD51 on single-strand DNA, which, in the case of recombining switch regions, promotes intraswitch recombination and, in the setting of BRCA1 deficiency, restores HR (Bouwman et al., 2010; Bunting et al., 2010; Cao et al., 2009) . Thus, DNA end protection by 53BP1 is critical for CSR in G1 but can unleash genome instability in S phase.
In addition to DNA end-blocking activities that disfavor HR and thereby promote NHEJ, 53BP1 has been suggested to directly mediate long-range chromosomal interactions and DSB mobility that facilitates the juxtaposition of distal DNA ends. These activities are believed to be responsible for 53BP1's ability to support recombination of DSB ends that are far apart during V(D)J recombination and class switch recombination (Callé n et al., 2007b; Difilippantonio et al., 2008) and to fuse uncapped telomeric DNA ends (Dimitrova et al., 2008) . Both pro-NHEJ and anti-HR functions require the direct physical association of 53BP1 with DNA ends but also necessitate the DSB-induced phosphorylation of its N-terminal ATM/ATR kinase sites (Bothmer et al., 2011; Ward et al., 2006) .
The DNA damage response (DDR) protein RIF1 was recently identified as an essential factor recruited by phosphorylated 53BP1 to promote NHEJ and block HR (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Díaz et al., 2013; Feng et al., 2013; Zimmermann et al., 2013) . Like 53BP1, RIF1 is required for CSR (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Díaz et al., 2013) . Although the NHEJ of dysfunctional telomeres is abrogated in cells lacking 53BP1 or in cells expressing 53BP1
28A , an allele harboring alanine substitutions at all 28 N-terminal ATM/ATR kinase phosphorylation targets sites, loss of RIF1 has considerably milder defect (Zimmermann et al., 2013) . Moreover, although the generation of toxic radial chromosomes in BRCA1-deficient cells is prevented in 53BP1 À/À or in 53BP1 28A mutant cells (Bothmer et al., 2011; Bouwman et al., 2010; Bunting et al., 2012; Bunting et al., 2010) , the loss of RIF1 only partially rescues HR in BRCA1-deficient cells (Escribano-Díaz et al., 2013; Feng et al., 2013; Zimmermann et al., 2013) . This suggests that additional phosphorylation-dependent but RIF1-independent activities of 53BP1 might regulate the balance between HR and NHEJ.
PTIP is a ubiquitously expressed nuclear protein that associates constitutively with two of the known histone methyltransferases that catalyze trimethylation of histone H3 at lysine 4 (H3K4me3), MLL3, and MLL4 (Cho et al., 2007; Patel et al., 2007) . In addition to its well-established role in transcription initiation, a separate pool of PTIP functions in an unknown capacity in the DDR (Gong et al., 2009) . Indeed, PTIP has been implicated in both HR and NHEJ (Callen et al., 2012) . PTIP is recruited to DSBs by its tandem BRCT (BRCA1 carboxyl-terminal) domains (Manke et al., 2003; Yu et al., 2003) , which associate with the serine 25 phosphorylation site within the N terminus of 53BP1 (Munoz et al., 2007) . In contrast to RIF1, PTIP recruitment to DSBs was reported to be 53BP1 and ATM independent (Gong et al., 2009; Jowsey et al., 2004; Munoz et al., 2007) . Thus, the mechanism by which PTIP is recruited to DSBs, its role in DSB repair, and the physiological significance of PTIP interaction with 53BP1 remain unclear. Here, we show that PTIP is required for 53BP1-mediated inhibition of HR in BRCA1-deficient cells but is dispensable for 53BP1-initiated DSB repair during productive CSR. Thus, RIF1 and PTIP separate 53BP1 functions in productive and pathologic DSB repair.
RESULTS

A Separation of Function Mutation in 53BP1
To determine whether 53BP1's activities in NHEJ and HR are distinct, we compared 53BP1 8A , which disrupts phosphorylation of the eight N-terminal ATM/ATR target sites ( Figure 1A ), to the 53BP1 DB allele, which is indistinguishable from WT 53BP1 in all functional aspects (Bothmer et al., 2011) . To assay for CSR, BRCA1/53BP1-deficient B cells were transduced with wild-type and 53BP1 mutant proteins by retroviral infection after activation with lipopolysaccharide (LPS) and interleukin-4 (IL4). As expected, 53BP1
DB fully complemented the CSR defects ( Figure 1B ) and produced high levels of genome instability in PARPi-treated BRCA1/53BP1-deficient cells ( Figure 1C ) (Bothmer et al., 2011) . Surprisingly, despite rescuing CSR, the 53BP1 8A allele failed to promote genome instability in PARPitreated BRCA1/53BP1-deficient cells above the levels observed in controls ( Figure 1C ). This effect was not due to differences in the expression levels of 53BP1 ( Figure 1D ) or in the recruitment of 53BP1 and RIF1 to DSBs ( Figure 1E ). Similar to B cells, BRCA1/53BP1-deficient MEFs complemented with 53BP1 DB were hypersensitive to PARPi, whereas 53BP1 8A transduced
MEFs were not ( Figure S1 available online). Thus, the mechanism by which 53BP1 promotes CSR and blocks HR in BRCA1-deficient cells is distinct. Moreover, the recruitment of RIF1 is insufficient to induce genome instability in PARPi-treated BRCA1-deficient cells.
Role of PTIP in the DNA Damage Response Upon DNA damage, PTIP binds to the serine 25 residue within the N terminus of 53BP1 (Munoz et al., 2007) , which is located within the eight N-terminal sites mutated in 53BP1
8A
. Consistent with this, immunoprecipitation analysis revealed that PTIP association with 53BP1 after irradiation was abrogated in cells expressing S25A-harboring mutants 53BP1   8A   , 53BP1 15A , or 53BP1 28A (Figures 2A and S2A ). In contrast, the damageinduced 53BP1/PTIP interaction was maintained in the 53BP1 7A mutant, comprising alanine substitutions of 7 S/TQ phosphorylation sites C terminus of those mutated in 53BP1
( Figures 1A and S2A) .
To explore the function of PTIP in the DDR, we asked whether PTIP-deficient cells are sensitive to DNA damaging agents that are predominantly repaired by HR (Sonoda et al., 2006) . WT and PTIP À/À MEFs were exposed to either cisplatin, camptothecin, or PARPi, all of which sensitize HR-deficient cells (Bryant et al., 2005; Farmer et al., 2005 (Gong et al., 2009; Jowsey et al., 2004; Munoz et al., 2007) . Moreover, 53BP1 8A MEFs exhibited increased genome instability and reduced cell survival following IR ( Figures  S2C and S2D ). To examine the recruitment of HR proteins to DSBs, we evaluated BRCA1, RAD51, and g-H2AX foci formation after IR in WT and PTIP À/À MEFs. All of these factors were normally recruited to DSBs in PTIP-deficient cells ( Figure S2E ). Moreover, 53BP1 also formed robust foci in the absence of PTIP ( Figure S2E ). Thus, PTIP À/À MEFs are tolerant to agents that are highly toxic to HR-deficient cells and the recruitment of several factors implicated in DSB repair is intact in the absence of PTIP. Nevertheless, both PTIP À/À and 53BP1
MEFs are sensitive to IR.
PTIP Is Dispensable for NHEJ during CSR but Is Required for NHEJ of Dysfunctional Telomeres
To explore the role of PTIP in NHEJ, we first assayed CSR. Deletion of PTIP in B cells leads to a defect in class switching to IgG3, IgG2b, and IgG1 (Daniel et al., 2010; Schwab et al., 2011) . By recruiting an MLL-like methyltransferase complex to the switch regions of these isotypes, PTIP promotes histone modifications and transcription initiation of IgG3/IgG2b/IgG1 germline switch regions, which are necessary for AID targeting (Daniel et al., 2010; Schwab et al., 2011) . However, PTIP does not affect transcription at Igm and Igε (Daniel et al., 2010) , indicating that PTIPassociated methyltransferase complex promotes the accessibility of some but not all switch loci. To distinguish between PTIP's effects on transcription versus DSB repair, we compared CSR to IgG1 and IgE on day 5 after stimulation with aCD40+IL4 as described (Wesemann et al., 2011) .
) B cells displayed a defect in switching to IgG1 ( Figures 3A and 3B) , which is consistent with decreased Igg1 germline transcription (Daniel et al., 2010; Schwab et al., 2011) . However, there was no defect in IgE germline transcription (Daniel et al., 2010) or IgE CSR in PTIP-deficient cells (Figures 3A and 3B) . Indeed, IgE CSR was consistently higher in the absence of PTIP, likely because Sg1 is no longer a target for AID. In contrast to PTIP
) B cells impaired CSR to both IgG1 and IgE (Figures 3A and 3B) . We conclude that loss of PTIP phenocopies the 53BP1 8A mutant allele in that neither has a significant impact on NHEJ during CSR. An alternative end-joining pathway can catalyze substantial CSR end-joining to IgG1 and IgE even in the absence of classical NHEJ (Boboila et al., 2010) . Loss of PTIP leads to IR sensitivity but tolerance to agents that are repaired by HR. We therefore speculated that PTIP might function in other reactions besides CSR that might rely on classical NHEJ, such as the fusion of dysfunctional telomeres. When the shelterin factor TRF2 is removed, deprotected telomeres trigger ATM-dependent phosphorylation of 53BP1, and the ends are processed by NHEJ to generate chromosome fusions (Celli et al., 2006; Rai et al., 2010; Zimmermann et al., 2013) . Because ATM-dependent phosphorylation of 53BP1 is also required for interaction between 53BP1 and PTIP (Figures 2A and S2A) (Jowsey et al., 2004; Manke et al., 2003) , we asked whether PTIP promotes NHEJ-mediated fusion of deprotected telomeres. To address this, we uncapped telomeres in SV40-immortalized WT and PTIP À/À MEFs by removing TRF2 with short hairpin RNA against TRF2 (Rai et al., 2010) . Upon TRF2 depletion we observed a similar level of phosphorylation of the ATM target KAP-1 in WT and PTIP À/À MEFs, as measured by quantitative flow cytometry ( Figure 4A ). Consistent with this, there was an accumulation of cytologically discernable telomere-induced DNA damage foci (TIFs) containing g-H2AX in WT and PTIP À/À cells ( Figure 4B ).
Despite a robust DNA damage response and activation of ATM, the frequency of end-end chromosomal fusions was reduced by 2.8-fold in PTIP À/À MEFs relative to WT (Figures 4C and 4D) . Whereas 42% of WT cells bearing fusions had more than 30% of their chromosome ends fused, only 13% of PTIP KO cells had greater than 30% of their ends fused ( Figure 4E ). Thus, PTIP deficiency results in a reduction in the number of long-chain telomere fusions when telomeres are deprotected. We conclude that PTIP contributes to the NHEJ of dysfunctional telomeres.
PTIP Promotes Genome Instability in BRCA1-Deficient Cells
In contrast to 53BP1, loss of RIF1 only partially reverses the chromosomal aberrations and hypersensitivity produced by PARPi treatment of BRCA1-deficient cells (Escribano-Díaz et al., 2013; Zimmermann et al., 2013) . To determine whether PTIP could overcome the HR defects in BRCA1-deficient cells, we crossed PTIP f/f and BRCA1 f(D11)/f(D11) mice with CD19 CRE transgenic mice to simultaneously delete PTIP and exon 11 of BRCA1 in primary B lymphocytes. When unchallenged, BRCA1
) doubly deficient B cells divided normally as determined by carboxyfluorescein succinimidyl ester (CFSE) dye dilution ( Figure 5A ) and cell-cycle distribution ( Figure Figure 5C ). Thus, ablation of PTIP phenocopies both the 53BP1 8A mutation (Figure 1C) and 53BP1 deficiency (Bouwman et al., 2010; Bunting et al., 2010; Cao et al., 2009) in that it promotes genome stability and survival in BRCA1 mutant cells.
Loss of PTIP Increases HR in BRCA1 Mutant Cells by
Promoting DSB Resection BRCA1 and RAD51 function in a common HR pathway that promotes RAD51-mediated DNA strand exchange (Bhattacharyya et al., 2000; Moynahan et al., 1999; Scully et al., 1997) . Loss of 53BP1 rescues RAD51 foci formation and HR in 
53BP1
À/À B cells infected with EV, 53BP1 DB or 53BP1 8A retroviruses were assayed for IRIF (10 Gy, 2 hr recovery) for RIF1 (red, top), and 53BP1 (red, bottom). Cells were counterstained with DAPI (blue). Scale bar, 10 mm. See also Figure S1 .
BRCA1-deficient cells (Bouwman et al., 2010; Bunting et al., 2010) . To explore whether PTIP deficiency also promotes HR in BRCA1-deficient cells, we irradiated WT, BRCA1
B cells and measured the frequency of immunofluorescent RAD51 foci. All mutant cells proliferated similarly to WT over the course of 3 days ( Figure 5A ), and as expected, RAD51 foci were reduced in IR-treated BRCA1 À/À cells ( Figure 5D ). However, in PTIP À/À cells, the frequency of RAD51
foci was greater than WT, and RAD51 foci were normalized to WT levels in BRCA1 Figure 5D ). These results suggest that loss of PTIP reverses the HR defect in BRCA1-deficient cells, thereby explaining the insensitivity of BRCA1
Loss of PTIP might promote RAD51 foci formation by allowing increased resection of DSBs; this is similar to what happens with the loss of 53BP1 (Bunting et al., 2010; Difilippantonio et al., 2008) . Because 5 0 /3 0 DSB end resection produces RPA-coated single-strand DNA, we monitored RPA foci formation by high content microscopy. Irradiated PTIP À/À cells exhibited a significant increase in the mean number of RPA foci per cell relative to WT ( Figure 5E ); moreover, the fraction of PTIP À/À cells that had more than 15 RPA foci following IR was approximately 2-fold greater than WT ( Figure 5E ). Thus, PTIP limits the amount of chromatin bound RPA at IR-induced DSBs.
PTIP Recruitment to DSBs Promotes Radial Chromosomes in BRCA1-Deficient Cells
PTIP is a subunit of the MLL3/4 methyltransferase complex and promotes histone H3 lysine 4 trimethylation and transcription initiation at specific promoters, such as the Sg3/Sg1 switch regions of the Igh locus (Daniel et al., 2010 ) ( Figure S3A ). To determine whether transcription of DDR genes is altered by PTIP ablation, we profiled the transcriptome of WT and PTIP À/À B cells. Overall, there were 471 RefSeq annotated genes that were deregulated by more than 5-fold in PTIP À/À versus WT ( Figure S3B ). However, HR and NHEJ DNA damage response genes were not among deregulated pathways (Figures S3B and S3C) . This suggests that the functions of PTIP in suppressing HR might be unrelated to its role in transcriptional regulation.
To determine whether PTIP recruitment to DSBs is essential for its effects on HR, we made use of a point mutation in the BRCT domain 3 (W663R) of PTIP that selectively blocks its interaction with 53BP1 (Gong et al., 2009; Munoz et al., 2007) and is unable to form foci ( Figure S4A ) (Daniel et al., 2010) but retains PTIP association with the MLL3/4 complex, which is dependent on BRCT (domains 5 and 6) (Patel et al., 2007 MEFs and irradiated them with 10 Gy ( Figure 6A ). Although PTIP ionizing-irradiation-induced foci (IRIF) were detectable in nearly all WT cells, PTIP IRIF formation was impaired in the absence of 53BP1 or ATM ( Figure 6A ). Measurements of colocalization coefficients of g-H2AX (a marker of the DNA breaks) with PTIP in irradiated WT, 53BP1 À/À , and ATM À/À MEFs revealed that 80% of g-H2AX foci in WT cells contained PTIP, whereas less than 15% and 10% of g-H2AX foci in the 53BP1 À/À and ATM À/À cells, respectively, contained PTIP.
Consistent with these findings, PTIP IRIF was highly sensitive to pharmacological inhibition of ATM (ATMi), less sensitive to ATRi treatment, and insensitive to DNA-PKi. (Figure S5 ). These findings contrast with previous reports suggesting that PTIP, 53BP1, and ATM are independently recruited to DSBs (Gong et al., 2009; Jowsey et al., 2004; Munoz et al., 2007) . Because available PTIP antibodies are unable to detect endogenous PTIP foci, we used laser microirradiation to generate DSBs in WT, 53BP1
À/À
, and ATM À/À MEFs. In WT cells, PTIP was recruited to laser scissors-induced DSBs, which colocalized with g-H2AX ( Figure 6B ). Consistent with our analysis of IRIF, PTIP recruitment to DNA damage sites was 53BP1 and ATM dependent ( Figure 6B ). Moreover, PTIP failed to be recruited to DSBs in 53BP1 À/À MEFs reconstituted with a mutant protein lacking all 28 N-terminal S/TQ phosphorylation sites of 53BP1, 53BP1 28A ( Figure 6B ). We conclude that ATM-dependent phosphorylation of 53BP1 is necessary for PTIP recruitment to DSBs. Given that RIF1 is also recruited to DSBs in a 53BP1-and ATM-dependent manner (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Díaz et al., 2013; Feng et al., 2013; Silverman et al., 2004; Zimmermann et al., 2013) , we next monitored the codependency of PTIP and RIF1 for localization to DNA damage foci ( Figure 6C ). We found that 82% of PTIP IRIF colocalized , or 53BP1 28A retroviruses that were FLAG-tagged. Cells were irradiated (10 Gy, 45 min recovery) and immunoprecipitation was performed with anti-FLAG antibodies. Western blot analysis of PTIP and FLAG are shown for input (left) and immunoprecipitated protein (right). (B) Isogenic immortalized WT and PTIP À/À MEFs were either untreated or treated with irradiation (IR, 2 Gy), cisplatin (CisPt, 0.5 mM), camptothecin (CPT, 10 nM) or PARP inhibitor (PARPi, 1 mM) and chromosomal aberrations (chromatid breaks, chromosome breaks, and radials) were quantified in at least 50 metaphase spreads for each genotype and each treatment. Data from an independent experiment is shown in Figure S2B . with RIF1 foci and 78% of RIF1 colocalized with PTIP foci (Figure 6C , n > 800 foci). However, RIF1 was recruited to DNA damage sites in PTIP À/À MEFs ( Figure 6D ) and vice versa ( Figure 6E ).
Thus, RIF1 and PTIP are independently recruited to IRIF in a phospho-53BP1-dependent manner.
To further define the residues required for recruitment to phospho-53BP1, we examined PTIP and RIF1 recruitment in 53BP1 , and abrogated in 53BP1 15A mutant cells that lack all 8S/TQ and 7S/TQ phosphorylation sites ( Figures  7A-7C and S6B) . Thus, PTIP and RIF1 exhibit distinct phosphorylation-dependent interactions with 53BP1 that guide them to DSBs. The association of PTIP with the 8S/TQ sites on 53BP1 upon DNA damage (Figures 2A, 7 , and S6A) likely explains why loss of PTIP phenocopies 53BP1 8A with respect to CSR, irradiation sensitivity, and reversal of genome instability in BRCA1-deficient cells.
DISCUSSION
Regulation of DSB Repair Choice 53BP1 and BRCA1 play a critical role in channeling DSBs into either NHEJ or HR. 53BP1 promotes NHEJ in G1 by tethering DSBs together and by protecting these ends from exonuclease processing Difilippantonio et al., 2008) . In S phase, the inhibitory effect of 53BP1 on resection is antagonized by BRCA1 (Bouwman et al., 2010; Bunting et al., 2010) . Loss of BRCA1 results in a shift toward a mutagenic NHEJ pathway that results in chromosomal abnormalities, tumorigenesis, and embryonic lethality, but all of these phenotypes are relieved by 53BP1 deletion (Bouwman et al., 2010; Bunting et al., 2010; Cao et al., 2009) . In contrast, loss of classical NHEJ proteins (e.g., Ku, Ligase IV, DNA-PKcs) does not overcome the HR defects associated with BRCA1 deficiency (Bunting et al., 2012; Bunting et al., 2010) , perhaps because these factors play a more limited role in repressing 5 0 -3 0 resection (Bunting et al., 2012; Sfeir and de Lange, 2012) . Despite the striking rescue of BRCA1 deficiency, disrupting 53BP1 does not reverse the DNA repair defects associated with downstream mediators of the HR reaction (e.g., XRCC2, BRCA2, or PALB2) (Bouwman et al., 2010; BowmanColin et al., 2013; Bunting et al., 2010) . Thus, 53BP1 and BRCA1 oppose each other during critical initial stages of DSB repair before commitment to repair the ends by NHEJ or HR.
Mechanism of PTIP and RIF1 Association with 53BP1
The molecular events that are required for 53BP1 to promote the ligation of DNA ends during CSR and the aberrant chromosomal rearrangements in BRCA1 mutant cells were previously thought to be identical. Surprisingly our data suggest that the pro-NHEJ and anti-HR functions of 53BP1 are in fact distinct and separable activities that nevertheless require 53BP1 phosphorylation. These complementary aspects of 53BP1's activities are mediated by the independent recruitment of RIF1 and PTIP, respectively, to phosphorylated 53BP1.
PTIP contains BRCT domains that interact directly with phosphorylated 53BP1 (Manke et al., 2003; Munoz et al., 2007) . In contrast, RIF1 does not contain a known phosphorecognition motif, and it remains unclear how ATM-dependent phosphorylation facilitates RIF1 association with 53BP1. RIF1 may associate with 53BP1 directly or through interactions with effector molecules that contain BRCT phosphobinding modules ( Figure 7D ). Based on the observation that there is no detectable defect in RIF1 foci in 53BP1 8A cells ( Figures 7A and S6B) , we suspected that a major RIF1-interaction motif would reside C terminus of the 8S/TQ PTIP interaction sites. Consistent with this, the 53BP1 7A C-terminal mutant exhibits a reduction in RIF1 IRIF ( Figures 7A-7C ) and CSR (Bothmer et al., 2011) . RIF1 IRIF and CSR are further reduced in 53BP1 15A mutant cells that lack 8S/TQ and 7S/TQ sites ( Figures 7A and 7B ) (Bothmer et al., 2011) , suggesting that both regions contribute to RIF1 interactions with 53BP1 ( Figure 7D ). If so, we would predict some degree of competition between PTIP and RIF1 binding to 53BP1. Consistent with this, we have found an increased association between PTIP and 53BP1 in response to DNA damage in RIF1-deficient cells ( Figure S6C ). Thus, distinct from PTIP, RIF1 association with 53BP1 occurs via multidomain interactions ( Figure 7D ).
Role of PTIP and RIF1 in DSB Resection
Deletion of either PTIP or RIF1 leads to increased resection (Figure 5E ) (Chapman et al., 2013; Di Virgilio et al., 2013; EscribanoDíaz et al., 2013; Feng et al., 2013; Zimmermann et al., 2013) . However, whereas PTIP ablation rescues HR in BRCA1-deficient cells and is largely dispensable for NHEJ during CSR, RIF1 is essential for CSR and only partially contributes to the HR defects in BRCA1-deficient cells (Di Virgilio et al., 2013; Escribano-Díaz et al., 2013; Feng et al., 2013; Zimmermann et al., 2013) . How can these observations be reconciled? One possibility is that distinct S/TQ kinase target sites in 53BP1 are phosphorylated during CSR in G1 and during replication fork collapse in S, resulting in independent recruitment of the two factors to DNA ends in distinct phases of the cell cycle. Consistent with this idea, it was reported that the localization of RIF1 to DSBs is mainly restricted to G1 and is suppressed by BRCA1 in S/G2 (Chapman et al., 2013; Escribano-Díaz et al., 2013; Feng et al., 2013) . However, our finding that PTIP and RIF1 colocalize in the majority of irradiated cells and that both proteins form IRIF during G1 and S/G2 ( Figure S7) indicates that PTIP and RIF1 are not recruited to DSBs in distinct cell-cycle phases. Another possibility is that PTIP and RIF1 sites on 53BP1 are equally phosphorylated during the cell cycle but that these proteins might make the DSB-proximal chromatin refractory to a distinct set of nucleases. For example, initial DNA end resection is mediated by MRE11/RAD50/NBS1 and CTIP, whereas DNA2, EXO1, and BLM carry out more extensive resection (Symington and Gautier, 2011) , and RIF1 appears to be involved in protection against initial but not sustained resection (Feng et al., 2013) . In this model, the level of resection supported by loss of RIF1 would be insufficient for complete rescue of HR in BRCA1-deficient cells, which might require more extensive 3 0 single-strand tails. In contrast, ablation of PTIP supports the sustained resection required for the rescue of HR in BRCA1-deficient cells. Thus, RIF1 and PTIP may block different steps in resection or distinct nucleases that mediate HR.
Role of PTIP and RIF1 in Telomeric End-Joining
Depending on the nature of the break, RIF1 and PTIP might cooperate to promote NHEJ. For example, PTIP and RIF1 deficiency both result in IR sensitivity ( Figures 2B and 2C) (Feng et al., 2013) , and defective NHEJ of dysfunctional telomeres (Figure 4) (Chapman et al., 2013; Zimmermann et al., 2013) . It has been demonstrated that 53BP1 has RIF1-independent roles in promoting telomeric end-joining, evidenced by the considerably higher frequency of telomeric fusions in RIF1 Lottersberger et al., 2013; Zimmermann et al., 2013) . This RIF1-independent but phospho-53BP1-dependent function at telomeres has been linked to the induction of chromosome mobility (Zimmermann et al., 2013) , which increases the probability that DNA ends fuse. Because PTIP binds to DSBs in a 53BP1-dependent but RIF1-independent manner, it is possible that this 53BP1-dependent/RIF1-independent increase in telomere mobility is mediated by PTIP.
Implications for Cancer Therapy
The identification of separation of function mutations that selectively disrupt antirecombination functions of 53BP1 during replication fork collapse and CSR may open up new therapeutic opportunities. Breast cancers arising in BRCA1 mutation carriers frequently show low levels of 53BP1 expression (Bouwman et al., 2010) , which might result in resistance to PARPi therapy, a promising strategy for treating HR-deficient tumors (Bryant et al., 2005; Farmer et al., 2005) . Consistent with this, 53BP1 was lost in a fraction of BRCA1-deficient mouse mammary tumors that acquired PARPi resistance in vivo (Jaspers et al., 2013) . Interestingly, a fraction of PARPi-resistant tumors restored HR yet did not lose 53BP1. We speculate that PTIP mutation might emerge as a novel causal factor in PARPi resistance of BRCA1-deficient mammary tumors that restore HR. With respect to intervention, our study also suggests that it might be possible to increase HR in BRCA1 heterozygous carriers (legend continued on next page) without compromising B cell immunoglobulin class switching by inhibiting the recruitment of PTIP to DSBs.
EXPERIMENTAL PROCEDURES
Mice, MEFs, B Cell Culture, and Infections 53BP1 À/À (Ward et al., 2004) ,
f/f (Buonomo et al., 2009; Di Virgilio et al., 2013) , and PTIP f/f (Daniel et al., 2010) mice have been described. Resting splenic B cells were isolated from 8-to 12-week-old WT or mutant spleen with anti-CD43 microbeads (anti-Ly48; Miltenyi Biotech) and were cultured with LPS (25 mg/ml; Sigma) and IL-4 (5 ng/ml; Sigma) or aCD40 (1 mg/ml; eBiosciences) and IL4 as described (Barlow et al., 2013; Wesemann et al., 2011) . WT, 53BP1
À/À
, and ATM
À/À
MEFs were immortalized by SV40. SV40T immortalized PTIP f/f (Cho et al., 2009) and RIF1 f/f MEFs were infected with CRE viruses to delete PTIP and RIF1, respectively. PMX-PIE-based retroviruses encoding 53BP1 DB and 53BP1 8A were previously described (Bothmer et al., 2011) . Coding sequences 7A (**p < 0.001, one-tailed unpaired t test), and a greater percentage of very intense foci (z score > 3) are generated in 53BP1 DB compared to 53BP1 7A (blue box).
(D) Model for regulation of 53BP1 pro-NHEJ and anti-HR activities by distinct phosphointeractions with RIF1 and PTIP, respectively. PTIP binds to the 8S/TQ sites. RIF1 recruitment is largely dependent on C-terminal 7S/TQ sites, but RIF1 may also be stabilized by interactions with 8S/TQ. An unknown factor (X) may bind directly to phosphorylated 53BP1 and mediate RIF1 recruitment, whereas PTIP interaction with 53BP1 is direct (Munoz et al., 2007) . See also Figures S6 and S7.
for mouse PTIP WT /PTIP W663R and PTIP-GFP were cloned into the PMX-IRES-GFP and MIG-IRES-mCherry retroviral vectors, respectively. PARP (KU58948), ATM (Ku55933), and DNA-PK (NU7026) inhibitors were obtained from Astra Zeneca and ATRi has recently been described (Toledo et al., 2011) .
Flow Cytometry, Metaphase Analysis, and Telomere FISH For FACs analysis, splenic B cells were stained with fluorochrome-conjugated anti-B220, anti-igG1, and anti-igE antibodies (PharMingen) as described (Wesemann et al., 2011) . Carboxyfluorescein succinimidyl esther (CFSE) labeling was performed to track cell division. Samples were acquired on a FACSCalibur (Becton Dickinson), and cell sorting was preformed on a FACsAria (Becton Dickinson). Cells were harvested for metaphase analysis as described (Callé n et al., 2007a) . The murine TRF2 shRNA-targeting construct and MEF retroviral infection have been described (Rai et al., 2010) .
Telomere-induced foci were visualized by hybrization with anti-mouse g-H2AX antibody (Upstate Biotechnology) together with PNA probe (Applied Biosystems). Phosphorylated Kap-1 was detected by flow cytometry after intracellular staining using the BD Cytofix/Cytoperm kit (BD Biosciences).
DNA Damage, Laser Microirradiation, Immunoprecipitation, and RNA-Sequencing Cells were treated with different DNA damaging agents (IR, CPT, CisPt, and PARPi), and colony survival was assessed after 14 days, or metaphase analysis was performed 24 hr after treatment. For immunofluorescent staining, cells were irradiated with indicated doses of ionizing radiation, allowed to recover, and then fixed and processed as described (Celeste et al., 2003) . For microirradiation, cells were presensitized in DMEM media containing 0.1 mg/ml of Hoechst 33342 for 60 min before replacing with phenol red free media containing 5 mM HEPES, and then irradiated with the 364 nm laser line on a LSM510 confocal microscope (Zeiss) equipped with a heated stage. Cells were allowed to recover for 15 min prior to processing for immunofluorescence. Analysis of RPA foci was performed using an Opera High-Content Screening system as described . Primary antibodies for immunofluorescence were rabbit anti-53BP1 (Novus), mouse anti-g-H2AX (Upstate Biotechnology), mouse or rabbit anti-FLAG-M2 (Sigma), mouse anti-AIM1 (Becton Dickinson), mouse anti-GFP (Roche), rabbit anti-RAD51 (Santa Cruz), rat anti-RPA (Cell Signaling), rabbit-anti-PTIP (Cho et al., 2009) , and rabbit-anti-RIF1(Di Virgilio et al., 2013) . DNA was counterstained with DAPI. For immunoprecipitation, primary 53BP1 À/À B cells were infected with retroviral constructs. Ninety-six hours postactivation, cells were irradiated (10 Gy), left to recover for 45 min, and collected by centrifugation. Cells were lysed, sonicated, and cell lysates were incubated with magnetic beads (M-270 epoxy beads, Invitrogen) conjugated with anti-Flag M2 antibody (Di Virgilio et al., 2013) . 53BP1-associated proteins were eluted by incubation in NuPAGE LDS sample buffer (Invitrogen) supplemented with 45 mM DTT for 10 min at 72 C. For RNA sequencing, reads from each cDNA library were mapped onto the Build 37 assembly of the National Center for Biotechnology Information mouse genome data (July 2007; NCBI37/mm9) using TopHat. Bioconductor (Gentleman et al., 2004) was used to calculate the RPKM (reads per kilobase exon model per million mapped reads) of the RefSeq annotated genes.
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